Clobetasol Completed Phase 2 Trials for Oral Chronic Graft vs Host Disease Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01557517Clobetasol for Oral Graft-Versus-Host Disease